BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1058832)

  • 1. Cell mediated immunity in human osteogenic sarcoma.
    Agashe SS; Nair PN; Rao RS; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):61-6. PubMed ID: 1058832
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 3. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
    Bloom ET
    Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell mediated immunity in osteogenic sarcoma. Role of the regional lymph nodes.
    Rao RS; Agashe SS; Nair PN; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):56-60. PubMed ID: 1058831
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular immunity in human osteogenic sarcoma.
    Gangal SG; Agashe SS; Nair PN; Rao RS
    Indian J Cancer; 1973 Sep; 10(3):295-301. PubMed ID: 4522531
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of cellular immunity indices in patients with malignant tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA
    Vopr Onkol; 1973; 19(11):18-21. PubMed ID: 4522541
    [No Abstract]   [Full Text] [Related]  

  • 7. [Characteristics of the immunohematologic status of patients with malignant bone neoplasms].
    Zhukovskiĭ IIa; Bizer VA
    Ter Arkh; 1978; 50(7):95-7. PubMed ID: 362593
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating antibodies in human connective tissue malignancy.
    Moore M; Hughes LA
    Br J Cancer Suppl; 1973 Aug; 1():175-84. PubMed ID: 4613373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunofluorescence tests on sera of patients with osteogenic sarcoma.
    Priori ES; Wilbur JR; Dmochowski L
    J Natl Cancer Inst; 1971 Jun; 46(6):1299-308. PubMed ID: 4932429
    [No Abstract]   [Full Text] [Related]  

  • 10. Disapperance of osteogenic sarcoma after irradiation: immunologic observations.
    Urtasun RC; Connachie PR
    J Can Assoc Radiol; 1976 Jun; 27(2):80-3. PubMed ID: 1066352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-specific cell-mediated immunity in household contacts of cancer patients.
    Byers VS; Levin AS; Hackett AJ; Fudenberg HH
    J Clin Invest; 1975 Mar; 55(3):500-13. PubMed ID: 1078827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO; Spitler LE
    J Clin Invest; 1975 Mar; 55(3):487-99. PubMed ID: 1078826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous expression of Fas and nonfunctional Fas ligand in Ewing's sarcoma.
    Kontny HU; Lehrnbecher TM; Chanock SJ; Mackall CL
    Cancer Res; 1998 Dec; 58(24):5842-9. PubMed ID: 9865744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-immunological studies of 32 cases of bone tumors].
    Franchi F; Russo V; Luzi G; Santori FS; De Chiara N; Aiuti F
    Minerva Med; 1980 Jun; 71(25):1815-22. PubMed ID: 6968049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selected immunologic indicators in malignant bone tumors].
    Keleová A; Huraj E; Jahnová E; Janota S; Nyulassy S
    Acta Chir Orthop Traumatol Cech; 1990 Feb; 57(1):77-88. PubMed ID: 2336911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphocyte and serum-mediated immunity in murine osteosarcoma.
    Miller CW; Fisher SJ
    J Bone Joint Surg Am; 1977 Oct; 59(7):981-3. PubMed ID: 269112
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfer factor therapy in osteogenic sarcoma.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO
    Trans Assoc Am Physicians; 1974; 87():153-8. PubMed ID: 4549141
    [No Abstract]   [Full Text] [Related]  

  • 18. Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma.
    Yu A; Watts H; Jaffe N; Parkman R
    N Engl J Med; 1977 Jul; 297(3):121-7. PubMed ID: 325412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma.
    Heiner JP; Miraldi F; Kallick S; Makley J; Neely J; Smith-Mensah WH; Cheung NK
    Cancer Res; 1987 Oct; 47(20):5377-81. PubMed ID: 3115567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity of human peripheral lymphocytes for glioma, osteosarcoma, and glia cell lines.
    Skurzak H; Steiner L; Klein E; Lamon E
    Natl Cancer Inst Monogr; 1973 Jun; 37():93-102. PubMed ID: 4514736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.